| Business Summary | | Vision-Sciences,
Inc.
develops,
manufactures
and
markets
products
for
endoscopy,
the
science
of
using
an
instrument,
known
as
an
endoscope,
to
provide
minimally
invasive
access
to
areas
not
readily
visible
to
the
human
eye.
The
Company
operates
in
three
reportable
segments:
medical,
industrial,
and
corporate.
The
medical
segment
designs,
manufactures
and
sells
an
EndoSheath
System,
a
single-use
device
that
slides
on
to
the
insertion
tube
of
a
flexible
endoscope.
The
EndoSheath
gives
health-care
providers
economic
advantages
compared
to
using
conventional
flexible
endoscopes,
as
utilizing
the
EndoSheath
allows
them
to
avoid
the
burdensome
cleaning
required
of
conventional
endoscopes.
In
addition,
the
EndoSheath
is
a
sterile
device
that
provides
patients
with
a
contaminant-free
procedure. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Vision-Sciences,
Inc.
develops,
manufactures
and
markets
products
for
endoscopy
that
have
infection
control
advantages
over
conventional
flexible
endoscopes
designed
to
eliminate
the
risk
of
cross-contamination
to
patients
and
health
care
professionals.
For
the
fiscal
year
ended
3/31/01,
net
sales
rose
2%
to
$7.2
million.
Net
loss
fell
73%
to
$1.3
million.
Results
reflect
higher
demand
by
international
distributors
for
the
ENT
EndoSheath,
and
lower
equity
loss
on
3DV
Systems
Ltd. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
1,730;
after
tax
earnings
were
-875. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2001 Pay | |
| Katsumi Oneda, 63 Chairman,
Pres, CEO | $109K | Lewis Pell, 58 Vice
Chairman of Directors | 111K | James Tracy, 52 VP
of Fin. | 105K | Isao Fujimoto, 53 VP
Manufacturing and Engineering of the Industrial Segment | 118K | Mark Landman, 47 VP
Operations of the Medical Segment | 103K | Dollar amounts are as of 31-Mar-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|